Pentoxifylline (PTX), an anti-hemorrhage drug used in the treatment of intermittent claudication, is extensively metabolized by the liver resulting in a reduction of the therapeutic levels within a short duration of time. Self-nano-emulsifying drug delivery system (SNEDDS) is well reported to enhance the bio-absorption of drugs by forming nano-sized globules upon contact with the biological fluids after oral administration. The present study aimed to formulate, characterize, and improve the oral bioavailability of PTX using SNEDDS. The formulated SNEDDS consisted of palm oil, Capmul® MCM, and Tween® 80 as oil, surfactant, and co-surfactant, respectively. The mixture design module under the umbrella of the design of experiments was used for the optimization of SNEDDS. The dynamic light-scattering technique was used to confirm the formation of nanoemulsion based on the globule size, in addition to the turbidity measurements. In vivo bioavailability studies were carried out on male Wistar rats. The pharmacokinetic parameters upon oral administration were calculated using the GastroPlus software. The optimized SNEDDS had a mean globule size of 165 nm with minimal turbidity in an aqueous medium. Bioavailability of PTX increased 1.5-folds (AUC = 1013.30 ng h/mL) as SNEDDS than the pure drug with an AUC of 673.10 ng h/mL. In conclusion, SNEDDS was seen to enhance the bioavailability of PTX and can be explored to effectively control the incidents of intermittent claudication.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev. 2015;9(9):CD005262.
Patel SK, Surowiec SM. Intermittent claudication [internet]. StatPearls. Treasure Island: StatPearls Publishing; 2019.
Cassar K. Intermittent claudication. BMJ. 2006;333(7576):1002–5.
Yentes JM, Huisinga JM, Myers SA, Pipinos II, Johanning JM, Stergiou N. Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain. J Appl Biomech. 2012;28(2):184–91.
McCarty MF, O’Keefe JH, DiNicolantonio JJ. Pentoxifylline for vascular health: a brief review of the literature. Open Heart. 2016;3(1):e000365.
Chen Y-M, Chiang W-C, Lin S-L, Tsai T-J. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update. J Biomed Sci. 2017;24(1):84.
Dorner GT, Zawinka C, Resch H, Wolzt M, Schmetterer L, Garhofer G. Effects of pentoxifylline and alprostadil on ocular hemodynamics in healthy humans. Investig Opthalmol Vis Sci. 2007;48(2):815.
Incandela L, Cesarone MR, Belcaro G, De Sanctis MT, Nicolaides AN, Griffin M, et al. Treatment of vascular inner ear disease with pentoxifylline: a 4-week, controlled, randomized trial. Angiology. 53(Suppl 1):S19–22.
Magnusson M, Gunnarsson M, Berntorp E, Björkman S, Höglund P. Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans. Eur J Pharmacol. 2008;581(3):290–5.
Zhang M, Xu Y-J, Mengi SA, Arneja AS, Dhalla NS. Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol. 2004;9(2):103–11.
Best BM, Burns JC, DeVincenzo J, Phelps SJ, Blumer JL, Wilson JT, et al. Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in Kawasaki disease. Curr Ther Res Clin Exp. 2003;64(2):96–115.
Mauro VF, Mauro LS, Hageman JH. Comparison of Pentoxifylline pharmacokinetics between smokers and nonsmokers. J Clin Pharmacol. 1992;32(11):1054–8.
Ghate VM, Kodoth AK, Shah A, Vishalakshi B, Lewis SA. Colloidal nanostructured lipid carriers of pentoxifylline produced by microwave irradiation ameliorates imiquimod-induced psoriasis in mice. Colloids Surf B: Biointerfaces. 2019;181:389–99.
AL Shuwaili AH, Rasool BKA, Abdulrasool AA. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Eur J Pharm Biopharm. 2016;102:101–14.
Sant VP, Nagarsenker MS, Rao SGA, Gude RP. Enhancement of anti-metastatic activity of pentoxifylline by encapsulation in conventional liposomes and sterically stabilized liposomes in murine experimental B16F10 melanoma model. J Pharm Pharmacol. 2000;52(12):1461–6.
Yan KS, Yan TX, Guo H, Li JZ, Wei LL, Wang C, et al. Evaluation of transdermal permeability of pentoxifylline gel: In vitro skin permeation and in vivo microdialysis using Wistar rats. Drug Discov Ther. 2007;1(1):78–83.
Baloch J, Sohail MF, Sarwar HS, Kiani MH, Khan GM, Jahan S, et al. Self-nanoemulsifying drug delivery system (SNEDDS) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Medicina (Kaunas). 2019;55(5).
Singh B, Khurana L, Bandyopadhyay S, Kapil R, Katare OOP. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv. 2011;18(8):599–612.
Mancinelli A, Pace S, Marzo A, Arrigoni Martelli E, Passetti G. Determination of pentoxifylline and its metabolites in human plasma by high-performance liquid chromatography with solid-phase extraction. J Chromatogr B Biomed Sci Appl. 1992;575(1):101–7.
Yen C-C, Chang C-W, Hsu M-C, Wu Y-T. Self-nanoemulsifying drug delivery system for resveratrol: enhanced oral bioavailability and reduced physical fatigue in rats. Int J Mol Sci. 2017;18(9).
Avachat AM, Patel VG. Self nanoemulsifying drug delivery system of stabilized ellagic acid–phospholipid complex with improved dissolution and permeability. Saudi Pharm J. 2015;23(3):276–89.
Tran T, Rades T, Müllertz A. Formulation of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine and Kolliphor® RH40 using experimental design. Asian J Pharm Sci. 2018;13(6):536–45.
Kodoth AK, Ghate VM, Lewis SA, Badalamoole V. Application of pectin-zinc oxide hybrid nanocomposite in the delivery of a hydrophilic drug and a study of its isotherm, kinetics and release mechanism. Int J Biol Macromol. 2018;115:418–30.
Patel J, Patel A, Raval M, Sheth N. Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. J Adv Pharm Technol Res. 2011;2(1):9–16.
Eid AM, El-Enshasy HA, Aziz R, Elmarzugi NA. The preparation and evaluation of self-nanoemulsifying systems containing Swietenia oil and an examination of its anti-inflammatory effects. Int J Nanomedicine. 2014;9:4685–95.
Ghate VM, Kodoth AK, Vishalakshi B, Lewis SA. Development of MART for the rapid production of nanostructured lipid carriers loaded with all-trans retinoic acid for dermal delivery. AAPS PharmSciTech. 2019; (in press).
Shahba AA-W, Mohsin K, Alanazi FK. Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in-vitro assessment. AAPS PharmSciTech. 2012;13(3):967–77.
Kumar A, Jaiswal M. Effect of self nanoemulsifying drug delivery system (snedds) on intestinal permeation and anti-diabetic activity of;Berberis aristata extract: in-vitro and ex-vivo studies. J Nanopharmaceutics Drug Deliv. 2016;3(1):51–62.
Ke Z, Hou X, Jia X-B. Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Des Devel Ther. 2016;10:2049–60.
Kazi M, Al-Swairi M, Ahmad A, Raish M, Alanazi FK, Badran MM, et al. Evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for poorly water-soluble Talinolo: preparation, in vitro and in vivo assessment. Front Pharmacol. 2019;10:459.
Daga PR, Bolger MB, Haworth IS, Clark RD, Martin EJ. Physiologically based pharmacokinetic modeling in lead optimization. 1. Evaluation and adaptation of GastroPlus to predict bioavailability of Medchem series. Mol Pharm. 2018;15(3):821–30.
Hosea NA, Jones HM. Predicting pharmacokinetic profiles using in silico derived parameters. Mol Pharm. 2013;10(4):1207–15.
Zhang X, Lionberger RA, Davit BM, Yu LX. Utility of physiologically based absorption modeling in implementing quality by design in drug development. AAPS J. 2011;13(1):59–71.
Ali H, Prasad Verma PR, Dubey SK, Venkatesan J, Seo Y, Kim S-K, et al. In vitro–in vivo and pharmacokinetic evaluation of solid lipid nanoparticles of furosemide using Gastroplus™. RSC Adv. 2017;7(53):33314–26.
Sharma A, Benbrook DM, Woo S. Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2. Kim J, editor. PLoS One. 2018;13(4):e0194046.
Patel G, Shelat P, Lalwani A. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment. Drug Deliv. 2016;23(8):3027–42.
Taha EL, Al-Saidan S, Samy AM, Khan MA. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int J Pharm. 2004;285(1–2):109–19.
Caliph SM, Charman WN, Porter CJ. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balanace in lymph-cannulated and non-cannulated rats. J Pharm Sci. 2000;89:1073–84.
Porter CJ, CHarman WN. In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev. 2001;50(Suppl 1):S127–47.
Chudasama A, Patel V, Nivsarkar M, Vasu K, Shishoo C. Role of lipid-based excipients and their compostition on the bioavailability of antiretroviral self-emulsifying formulations. Drug Deliv. 2015;22(4):531–40.
Carriere F. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs. Biochimie. 2016;125:297–305.
Singh B, Garg B, Kaur R, Jain A, Kumar R, Katare O. Self-nanoemulsifying systems for oral bioavailability enhancement: Recent paradigms. In: Fabrication and Self-Assembly of Nanobiomaterial. Amsterdam: Elsevier; 2016. p. 91–115.
Qi X, Wang L, Zhu J, Hu Z, Zhang J. Self-double-emulsifying drug delivery systems (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability. Int J Pharm. 2011;409(1–2):245–51.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shailendrakumar, A.M., Ghate, V., Kinra, M. et al. Improved Oral Pharmacokinetics of Pentoxifylline with Palm Oil and Capmul® MCM Containing Self-Nano-Emulsifying Drug Delivery System. AAPS PharmSciTech 21, 118 (2020). https://doi.org/10.1208/s12249-020-01644-w
- Ternary phase diagram
- Mixture design
- Design space